← Back
September 1, 2020

Research coaction

As a result of our publication in JPET with University of Bristol, contact was established with Prof. Amynah Pradhan at the University of Illinois, Chicago.

We have now initiated a collaboration with Prof. Pradhan who is a world leader in delta opioid neurobiology with a particular interest in migraine and with Prof. Eamonn Kelly (University of Bristol) our existing research partner and opioid expert with the intention of applying for NIH funding to synthesize and test a range of new DORA structures. The aim is to develop new compounds for treating migraine and other headaches.

Success could lead to new patents following up on our lead compound PN6047 and entry into the large international migraine/headache market.

Author:

David Kendall

Research coaction

As a result of our publication in JPET with University of Bristol, contact was established with Prof. Amynah Pradhan at the University of Illinois, Chicago.

Read more →

New CEO appointed

The board of PharmNovo AB is pleased to announce that former VP Business Development Per von Mentzer assumed the position as new Chief Executive Officer of PharmNovo AB effective May 2020.

Read more →

JPET approves PN6047

In collaboration with our research partners at the University of Bristol, we have had a manuscript detailing the results of our preclinical studies of PN6047 accepted for publication in the highly cited Journal of Experimental Pharmacology and Therapeutics (JPET), the official journal of the American Society for Pharmacology and Experimental Therapeutics (ASPET).

Read more →

Moving into The Spark

In September PharmNovo AB officially moved to Medicon Village in Lund and the newly opened building ”The Spark”. Being located at Medicon Village offers great opportunities for networking and finding new collaboration and service partners. Being one of the largest life science hubs in the Nordics, Medicon is also a fantastic platform for marketing our company and attracting future investors and partners.

Read more →
Latest
breaking
news

Find us

PharmNovo AB
Medicon Village AB
Scheeletorget 1
SE-223 81 Lund, Sweden

Map